CVE-2026-21923
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).
Does this matter?
Lower severity and a low EPSS score (0.26%). Track it; it rarely justifies an emergency change on its own.
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
- CVSS 3.1
- 6.5 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
- EPSS
- 0.26% probability · 18th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Affected
- oracle/life sciences central designer
- Source
- secalert_us@oracle.com
EPSS 0.3% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://www.oracle.com/security-alerts/cpujan2026.htmlVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.